HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the information needed to use DILANTIN® safely and effectively. See full prescribing information for DILANTIN®. INFATABS® DILANTIN® (phenytoin chewable tablets), for oral use Initial U.S. Approval: 1953 RECENT MAJOR CHANGESINDICATIONS AND USAGEDILANTIN INFATABS are indicated for the treatment of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. (1) DOSAGE AND ADMINISTRATION
DOSAGE FORMS AND STRENGTHSDILANTIN INFATABS are available as 50 mg phenytoin scored chewable tablets. (3) CONTRAINDICATIONSWARNINGS AND PRECAUTIONS
ADVERSE REACTIONSThe most common adverse reactions are nervous system reactions, including nystagmus, ataxia, slurred speech, decreased coordination, somnolence, and mental confusion. (6) To report SUSPECTED ADVERSE REACTIONS, contact Pfizer, Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. DRUG INTERACTIONSUSE IN SPECIFIC POPULATIONSSee 17 for PATIENT COUNSELING INFORMATION and Medication Guide. Revised: 8/2019 |

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
DILANTIN® Infatabs®Highlights (phenytoin)
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at https://vaers.hhs.gov or call (800) 822-7967.